We invite you to use the learnings to guide your contribution to the debate on how to design a system for health that values effectiveness, equity and efficiency, and how we can improve preventive action on the basis of the best available evidence.
PUBLIC HEALTH ASSOCIATION OF AUSTRALIA
DHE has also collaborated with colleagues in Australian and overseas universities, including:
- Monash University
- University of Melbourne
- University of Sydney
- University of Technology Qld
- University of Queensland
- Flinders University
- Australian Catholic University
- Victoria University
- Oxford University
- Harvard University.
Assessing cost effectiveness (ACE) in prevention
This report evaluates 150 prevention interventions to inform which programs deliver value for money across a range of clinical areas.
The health and economic benefits of reducing disease risk factors
This report looks at the health and economics benefits of reducing disease risk factors. It quantifies the health status, financial and economic benefits of reducing the prevalence of the six behavioural risk factors: obesity, alcohol, smoking, exercise, diet and domestic violence.
Osteoporosis costing all Australians: A new burden of disease analysis 2012 to 2022
This report estimates the current and future economic costs of osteoporosis in Australia.
Highly accessed journal papers
Gortmaker SL, Swinburn BA, Levy D, Carter R, Mabry PL, Finegood DT, Huang T, Marsh T, Moodie ML: Changing the future of obesity: science, policy, and action. The Lancet, 378:838–847.
Mihalopoulos C, Harris M, Henry L, Harrigan S, McGorry P: Is early intervention in psychosis cost-effective over the long term? Schizophr Bull 2009, 35:909–918.
Shiell A, Hawe P, Gold L: Complex interventions or complex systems? Implications for health economic evaluation. BMJ 2008, 336:1281–1283.
Swinburn BA, Sacks G, Hall KD, McPherson K, Finegood DT, Moodie ML, Gortmaker SL: The global obesity pandemic: shaped by global drivers and local environments. The Lancet, 378:804–814.